Insulin resistance in relation to inflammatory gene expression and metabolic features in apparently healthy obese individuals

  • Parichehr Amiri
  • Mahsa Naghizadeh
  • Behzad Baradaran
  • Maryam Saghafi-AslEmail author
  • Dariush Shanehbandi
  • Susan Mirmajidi
Original Article


The present study aimed to investigate the association of insulin resistance (IR) with inflammatory gene expression levels, metabolic health, lipid profile, and body composition in the apparently healthy obese. In this cross-sectional study, 88 apparently healthy obese subjects were recruited and divided into insulin-resistant and non-insulin-resistant (NIR) groups. Fasting blood samples were taken to determine serum metabolic features. mRNA expression of inflammatory genes were assessed in freshly isolated peripheral blood mononuclear cells (PBMCs), using quantitative real-time PCR (qPCR). Bioelectrical impedance analysis (BIA) was used to describe body composition. Among inflammatory genes, toll-like receptor 4 (TLR4) mRNA revealed significant upregulation in PBMCs of IR group compared with NIR individuals (p = 0.035). High-density lipoprotein cholesterol (HDL-C, p = 0.04), low-density lipoprotein cholesterol (LDL-C, p < 0.001), waist circumference (p = 0.025), and waist to hip ratio (p = 0.013) were significantly different between the two groups. A significant but weak correlation of HDL-C was observed with TLR4 (r = − 0.305; p = 0.011) and myeloid differentiation factor 88 (MyD88, r = − 0.27; p = 0.024) expression level. Also, LDL-C was found to be correlated with TLR4 (r = 0.302; p = 0.012) and MyD88 (r = 0.267; p = 0.027) expression levels. There was also a significant correlation between HOMA-IR and HDL-C (r = − 0.25; p = 0.019). The results of this study indicated the possible link between IR and TLR4. Also, there was a significant correlation between HDL-C and LDL-C as well as between TLR4 and MyD88. Some inflammatory genes and metabolic parameters were also significantly correlated.


Insulin resistance Inflammatory genes Metabolic health Lipid profile Healthy obese 



Blood pressure


Body mass index


Fasting blood sugar


High-density lipoprotein cholesterol


Homeostasis model of insulin resistance


Insulin resistance


Low-density lipoprotein cholesterol


Metabolic syndrome


Metabolically healthy obese


Metabolically unhealthy obese


Myeloid differentiation factor 88


Nuclear factor kappa B


Non-insulin resistance


Peripheral blood mononuclear cells


Quantitative insulin sensitivity check index


Type 2 diabetes mellitus


Total cholesterol


TIR-domain containing adaptor-inducing interferon-β


Toll-like receptor 2


Toll-like receptor 4


Waist circumference


Waist/hip ratio



Thanks are due to all who participated in the study.

Authors’ contribution

MSA and PA wrote the study protocol and study design. BB and DS helped with qPCR. MSA and PA analyzed and interpreted the data. PA, MN, and SM helped with the sampling. PA and MSA were involved in drafting the manuscript or revising it critically for content. All authors have given final approval of the version to be published.


This study was financially supported by the Nutrition Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. The results of this paper were extracted from MSc. thesis of Parichehr Amiri, registered at Tabriz University of Medical Sciences.

Compliance with ethical standards

Competing interests

The authors declare that they have no conflict of interest.


  1. 1.
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.Google Scholar
  2. 2.
    Könner AC, Brüning JC. Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab. 2011;22(1):16–23.Google Scholar
  3. 3.
    Seidell JC. Obesity, insulin resistance and diabetes—a worldwide epidemic. Br J Nutr. 2000;83(S1):S5–8.Google Scholar
  4. 4.
    Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol. 1999;84(1):28–32.Google Scholar
  5. 5.
    Engfeldt P, Arner P. Lipolysis in human adipocytes, effects of cell size, age and of regional differences. Horm Metab Res Suppl Ser. 1988;19:26–9.Google Scholar
  6. 6.
    Veilleux A, Caron-Jobin M, Noël S, Laberge PY, Tchernof A. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes. 2011;60(5):1504–11.Google Scholar
  7. 7.
    Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84(1):137–44.Google Scholar
  8. 8.
    Raji A, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab. 2001;86(11):5366–71.Google Scholar
  9. 9.
    Lundgren H, Bengtsson C, Blohme G, Lapidus L, Sjöström L. Adiposity and adipose tissue distribution in relation to incidence of diabetes in women: results from a prospective population study in Gothenburg, Sweden. Int J Obes. 1989;13(4):413–23.Google Scholar
  10. 10.
    Ohlson L-O, Larsson B, Svärdsudd K, Welin L, Eriksson H, Wilhelmsen L, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes. 1985;34(10):1055–8.Google Scholar
  11. 11.
    Banerji M, Lebowitz J, Chaiken RL, Gordon D, Kral JG, Lebovitz HE. Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects. Am J Physiol Endocrinol Metab. 1997;273(2):E425–E32.Google Scholar
  12. 12.
    Curtiss LK, Tobias PS. Emerging role of toll-like receptors in atherosclerosis. J Lipid Res. 2009;50(Supplement):S340–S5.Google Scholar
  13. 13.
    Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid–induced insulin resistance. J Clin Investig. 2006;116(11):3015–25.Google Scholar
  14. 14.
    Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014;99(1):39–48.Google Scholar
  15. 15.
    Tripathy D, Mohanty P, Dhindsa S, Syed T, Ghanim H, Aljada A, et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 2003;52(12):2882–7.Google Scholar
  16. 16.
    Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4–7.Google Scholar
  17. 17.
    Poggi M, Bastelica D, Gual P, Iglesias M, Gremeaux T, Knauf C, et al. C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet. Diabetologia. 2007;50(6):1267–76.Google Scholar
  18. 18.
    Tsukumo DM, Carvalho-Filho MA, Carvalheira JB, Prada PO, Hirabara SM, Schenka AA, et al. Loss-of-function mutation in toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes. 2007;56(8):1986–98.Google Scholar
  19. 19.
    Caricilli AM, Nascimento PH, Pauli JR, Tsukumo DM, Velloso LA, Carvalheira JB, et al. Inhibition of toll-like receptor 2 expression improves insulin sensitivity and signaling in muscle and white adipose tissue of mice fed a high-fat diet. J Endocrinol. 2008;199(3):399–406.Google Scholar
  20. 20.
    Hardy OT, Kim A, Ciccarelli C, Hayman LL, Wiecha J. Increased toll-like receptor (TLR) mRNA expression in monocytes is a feature of metabolic syndrome in adolescents. Pediatr Obes. 2013;8(1):e19–23.Google Scholar
  21. 21.
    Gómez-Ambrosi J, Catalán V, Rodríguez A, Andrada P, Ramírez B, Ibáñez P, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37(10):2813–21.Google Scholar
  22. 22.
    Telle-Hansen V, Halvorsen B, Dalen K, Narverud I, Wesseltoft-Rao N, Granlund L, et al. Altered expression of genes involved in lipid metabolism in obese subjects with unfavourable phenotype. Genes Nutr. 2013;8(4):425–34.Google Scholar
  23. 23.
    Bollyky PL, Bice JB, Sweet IR, Falk BA, Gebe JA, Clark AE, et al. The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury. PLoS One. 2009;4(4):e5063.Google Scholar
  24. 24.
    Hutton MJ, Soukhatcheva G, Johnson JD, Verchere CB. Role of the TLR signaling molecule TRIF in β-cell function and glucose homeostasis. Islets. 2010;2(2):104–11.Google Scholar
  25. 25.
    Jialal I, Huet BA, Kaur H, Chien A, Devaraj S. Increased toll-like receptor activity in patients with metabolic syndrome. Diabetes Care. 2012;35(4):900–4.Google Scholar
  26. 26.
    Mirmiran P, Esmaillzadeh A, Azizi F. Detection of cardiovascular risk factors by anthropometric measures in Tehranian adults: receiver operating characteristic (ROC) curve analysis. Eur J Clin Nutr. 2004;58(8):1110–8.Google Scholar
  27. 27.
    Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab. 2006;91(8):2906–12.Google Scholar
  28. 28.
    Saghafi-Asl M, Amiri P, Naghizadeh M, Ghavami SM, Karamzad N. Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran. BMJ Open. 2017;7(5):e015910.Google Scholar
  29. 29.
    Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care. 2001;24(2):362–5.Google Scholar
  30. 30.
    Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.Google Scholar
  31. 31.
    Devaraj S, Dasu MR, Rockwood J, Winter W, Griffen SC, Jialal I. Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J Clin Endocrinol Metab. 2008;93(2):578–83.Google Scholar
  32. 32.
    Dasu MRDS, Zhao L, Hwang DH, Jialal I. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008;57:3090–8.Google Scholar
  33. 33.
    Faam B, Zarkesh M, Daneshpour MS, Azizi F, Hedayati M. The association between inflammatory markers and obesity-related factors in Tehranian adults: Tehran lipid and glucose study. Iran J Basic Med Sci. 2014;17(8):577.Google Scholar
  34. 34.
    Ruderman NB, Schneider SH, Berchtold P. The “metabolically-obese,” normal-weight individual. Am J Clin Nutr. 1981;34(8):1617–21.Google Scholar
  35. 35.
    Kim F, Pham M, Luttrell I, Bannerman DD, Tupper J, Thaler J, et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res. 2007;100(11):1589–96.Google Scholar
  36. 36.
    Dasu MR, Devaraj S, Park S, Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care. 2010;33(4):861–8.Google Scholar
  37. 37.
    Reyna SM, Ghosh S, Tantiwong P, Meka CR, Eagan P, Jenkinson CP, et al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes. 2008;57(10):2595–602.Google Scholar
  38. 38.
    Creely SJ, McTernan PG, Kusminski CM, Da Silva N, Khanolkar M, Evans M, et al. Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab. 2007;292(3):E740–E7.Google Scholar
  39. 39.
    Burchfiel CM, HAMMAN RF, MARSHALL JA, BAXTER J, KAHN LB, AMIRANI JJ. Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study. Am J Epidemiol. 1990;131(1):57–70.Google Scholar
  40. 40.
    Manolio TA, Savage PJ, Burke GL, Liu K, Wagenknecht LE, Sidney S, et al. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arterioscler Thromb Vasc Biol. 1990;10(3):430–6.Google Scholar
  41. 41.
    McKeigue PM, Miller G, Marmot M. Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol. 1989;42(7):597–609.Google Scholar
  42. 42.
    Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study. Arterioscler Thromb Vasc Biol. 1988;8(3):227–36.Google Scholar
  43. 43.
    Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism. 1988;37(4):338–45.Google Scholar
  44. 44.
    Wolfs MG, Rensen SS, Bruin-Van Dijk EJ, Verdam FJ, Greve J-W, Sanjabi B, et al. Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study. BMC Med Genet. 2010;3(1):34.Google Scholar
  45. 45.
    Van Linthout S, Spillmann F, Graiani G, Miteva K, Peng J, Van Craeyveld E, et al. Down-regulation of endothelial TLR4 signalling after apo AI gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med. 2011;89(2):151–60.Google Scholar
  46. 46.
    Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410–22.Google Scholar
  47. 47.
    Seimon TA, Nadolski MJ, Liao X, Magallon J, Nguyen M, Feric NT, et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metab. 2010;12(5):467–82.Google Scholar
  48. 48.
    Robins SJ, Rubins HB, Faas FH, Schaefer EJ, Elam MB, Anderson JW, et al. Insulin resistance and cardiovascular events with low HDL cholesterol. Diabetes Care. 2003;26(5):1513–7.Google Scholar
  49. 49.
    Shaikh AZ, Badade ZG, Thomas SS. Homa-Ir and Ratios of Tg/Hdl and Tc/Hdl as indicators of insulin resistance in patient with metabolic syndrome and type 2 diabetes mellitus. Indian J Appl Res. 2015;5(8):668–91.Google Scholar
  50. 50.
    Lemieux I, Pascot A, Couillard C, Lamarche BT, Tchernof A, Alméras N, et al. Hypertriglyceridemic waist. Circulation. 2000;102(2):179–84.Google Scholar
  51. 51.
    Reaven G. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res. 2005;2(3):105–12.Google Scholar

Copyright information

© Research Society for Study of Diabetes in India 2018

Authors and Affiliations

  • Parichehr Amiri
    • 1
    • 2
  • Mahsa Naghizadeh
    • 1
    • 2
  • Behzad Baradaran
    • 1
  • Maryam Saghafi-Asl
    • 3
    • 4
    Email author
  • Dariush Shanehbandi
    • 1
  • Susan Mirmajidi
    • 2
  1. 1.Immunology Research CenterTabriz University of Medical SciencesTabrizIran
  2. 2.Student Research CommitteeTabriz University of Medical SciencesTabrizIran
  3. 3.Nutrition Research Center, Department of Biochemistry and Diet Therapy, School of Nutrition and Food SciencesTabriz University of Medical SciencesTabrizIran
  4. 4.Department of Biochemistry and Diet Therapy, School of Nutrition and Food SciencesTabriz University of Medical SciencesTabrizIran

Personalised recommendations